Your browser doesn't support javascript.
loading
Immune checkpoint inhibitor-related dermatologic adverse events.
Geisler, Amaris N; Phillips, Gregory S; Barrios, Dulce M; Wu, Jennifer; Leung, Donald Y M; Moy, Andrea P; Kern, Jeffrey A; Lacouture, Mario E.
Affiliation
  • Geisler AN; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Phillips GS; State University of New York Downstate Health Sciences University, Brooklyn, New York.
  • Barrios DM; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Wu J; Chang Gung Memorial Hospital Linkou, Chang Gung University School of Medicine, Taoyuan, Taiwan.
  • Leung DYM; Division of Pediatric Allergy and Immunology, Department of Pediatrics, National Jewish Health, Denver, Colorado.
  • Moy AP; Department of Pathology, Memorial Sloan Kettering Cancer, New York, New York.
  • Kern JA; Division of Pediatric Allergy and Immunology, Department of Pediatrics, National Jewish Health, Denver, Colorado.
  • Lacouture ME; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medicine, New York, New York. Electronic address: lacoutum@mskcc.org.
J Am Acad Dermatol ; 83(5): 1255-1268, 2020 Nov.
Article in En | MEDLINE | ID: mdl-32454097

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Eruptions / Immune Checkpoint Inhibitors / Neoplasms Limits: Humans Language: En Journal: J Am Acad Dermatol Year: 2020 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Eruptions / Immune Checkpoint Inhibitors / Neoplasms Limits: Humans Language: En Journal: J Am Acad Dermatol Year: 2020 Document type: Article Country of publication: